News

Cancer Research UK and Newcastle University have recently announced a three year extension to their major strategic drug discovery alliance with Astex Pharmaceuticals, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics.

In late 2016, HEFCE invited long-term strategies from higher education institutions (HEIs) in receipt of a 2016-17 Higher Education Innovation Fund allocation to submit five-year knowledge exchange (KE) strategies, as the basis for release of future allocations. HEFCE commissioned researchers RSM PACEC to assess and provide advice to HEFCE on the strategies, and to produce an overview report.

Open and collaborative scientific research is vital to the discovery and translation of new knowledge into products and services that benefit society.

PraxisUnico/AURIL welcome the publication of ‘Transforming UK Translation’ by The Academy of Medical Sciences, Royal Academy of Engineering, Royal Society and the Wellcome Trust; the ambition it sets out to create a ‘vibrant translation system’ and the broad definition of translation used to cover a range of outputs and activities. We are particularly pleased to see the recognition it gives to the role of TTOs and their role in supporting research translation. The UK operates at world class standard in technology transfer practice in an environment that supports continuous improvement of standards of practice[1].